G Migneco

1.9k total citations
29 papers, 1.2k citations indexed

About

G Migneco is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, G Migneco has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in G Migneco's work include Cancer, Hypoxia, and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). G Migneco is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). G Migneco collaborates with scholars based in United Kingdom, United States and Italy. G Migneco's co-authors include Barbara Chiavarina, Michael P. Lisanti, Diana Whitaker‐Menezes, Ubaldo Martinez‐Outschoorn, Stephanos Pavlides, Richard G. Pestell, Federica Sotgia, Anthony Howell, Neal Flomenberg and Agnieszka K. Witkiewicz and has published in prestigious journals such as Clinical Cancer Research, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

G Migneco

28 papers receiving 1.2k citations

Peers

G Migneco
Mark A. Gregory United States
Alice Banh United States
Wei-Lei Yang United States
Marcus Bosenberg United States
Sherry A. Weppler Netherlands
G Migneco
Citations per year, relative to G Migneco G Migneco (= 1×) peers Robert F. Shearer

Countries citing papers authored by G Migneco

Since Specialization
Citations

This map shows the geographic impact of G Migneco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Migneco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Migneco more than expected).

Fields of papers citing papers by G Migneco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Migneco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Migneco. The network helps show where G Migneco may publish in the future.

Co-authorship network of co-authors of G Migneco

This figure shows the co-authorship network connecting the top 25 collaborators of G Migneco. A scholar is included among the top collaborators of G Migneco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Migneco. G Migneco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jennings, Victoria A., G Migneco, Nicola Ingram, et al.. (2024). Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment. Frontiers in Immunology. 15. 1500570–1500570. 1 indexed citations
2.
Wasson, Christopher W., Rebecca L. Ross, Cristina Antinozzi, et al.. (2024). The β-Secretase BACE1 Drives Fibroblast Activation in Systemic Sclerosis through the APP/β-Catenin/Notch Signaling Axis. Journal of Investigative Dermatology. 144(10). 2197–2210.e4. 4 indexed citations
3.
Migneco, G, Gina B. Scott, Jenny Down, et al.. (2021). Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche. Journal for ImmunoTherapy of Cancer. 9(3). e001803–e001803. 14 indexed citations
4.
Ross, Rebecca, Clarissa Corinaldesi, G Migneco, et al.. (2021). Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma. Annals of the Rheumatic Diseases. 80(7). 920–929. 43 indexed citations
5.
Ross, Rebecca L., Giuseppina Abignano, Christopher W. Wasson, et al.. (2020). SAT0281 BIOSAMPLES FROM AT RISK SSC PATIENTS SHOW CLASSIC PATHOLOGICAL SIGNS OF SCLERODERMA: OPPORTUNITY FOR DIAGNOSIS OF PRE-CLINICAL SSC. Annals of the Rheumatic Diseases. 79. 1085–1085. 1 indexed citations
6.
Jennings, Victoria A., Gina B. Scott, Karen J. Scott, et al.. (2019). Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition. Molecular Therapy. 27(6). 1139–1152. 47 indexed citations
7.
Parrish, Christopher, Gina B. Scott, G Migneco, et al.. (2015). Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia. Leukemia. 29(9). 1799–1810. 32 indexed citations
8.
Bonuccelli, Gloria, Diana Whitaker‐Menezes, Remedios Castelló-Cros, et al.. (2010). The reverse Warburg Effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle. 9(10). 1960–1971. 190 indexed citations
9.
Chiavarina, Barbara, Diana Whitaker‐Menezes, G Migneco, et al.. (2010). HIF1-alpha functions as a tumor promoter in cancer-associated fibroblasts, and as a tumor suppressor in breast cancer cells. Cell Cycle. 9(17). 3534–3551. 185 indexed citations
10.
Martinez‐Outschoorn, Ubaldo, Stephanos Pavlides, Diana Whitaker‐Menezes, et al.. (2010). Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle. 9(12). 2423–2433. 207 indexed citations
11.
Pavlides, Stephanos, Aristotelis Tsirigos, G Migneco, et al.. (2010). The autophagic tumor stroma model of cancer. Cell Cycle. 9(17). 3485–3505. 201 indexed citations
12.
Migneco, G, Diana Whitaker‐Menezes, Barbara Chiavarina, et al.. (2010). Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: Evidence for stromal-epithelial metabolic coupling. Cell Cycle. 9(12). 2412–2422. 126 indexed citations
13.
Martinez‐Outschoorn, Ubaldo, Diana Whitaker‐Menezes, Stephanos Pavlides, et al.. (2010). The autophagic tumor stroma model of cancer or “battery-operated tumor growth”. Cell Cycle. 9(21). 4297–4306. 131 indexed citations
14.
Soresi, Maurizio, S Tripi, A Cartabellotta, et al.. (1996). [Factors predicting the response to alpha-interferon therapy in patients with chronic hepatitis C].. PubMed. 87(4). 154–7. 2 indexed citations
15.
Caruso, Calogero, Giuseppina Candore, Diego Cigna, et al.. (1994). Serum Levels of Soluble IL‐2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis. Mediators of Inflammation. 3(3). 185–187. 3 indexed citations
16.
Attanasio, Philipp, et al.. (1990). [Maternal-fetal transmission of infection with hepatitis B virus: evaluation of viral markers in maternal and fetal biological materials and relation with the vaccine response].. PubMed. 110(5). 217–25. 2 indexed citations
17.
Fierro, Brigida, et al.. (1986). Peripheral nerve involvement in chronic liver disease. Clinical and electrophysiological study. Neurological Sciences. 7(6). 589–590. 3 indexed citations
18.
Mansueto, S, G Migneco, S Tripi, & Dario Picone. (1980). Simplified counter-immunoelectrophoresis (CIEP) with a commercially produced antigen on cellulose acetate membrane for the diagnosis of hydatidosis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 74(2). 260–261. 6 indexed citations
19.
Mansueto, S, et al.. (1979). [The complement fixation test in leishmaniasis. Comparison between an antigen extracted from leishmania cultures and one extracted from BCG].. PubMed. 70(38). 2611–4. 1 indexed citations
20.
Migneco, G, et al.. (1971). [Australia antigen in families of the hepatitis patients and in other subjects exposed to the possibility of contact with hepatitis. II].. PubMed. 23(12). 1111–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026